All this is closely related to a higher number of patients with T2DM, metabolic syndrome and obesity, in addition to a higher genetic risk related mainly with the presence of polymorphism PNPLA3 (Patatin like phospholipase domain-containing protein 3). Here, PNPLA3 is linked to metabolic syndrome.